Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Stewart Mearns MPS[/caption]
Overcoming challenges with disability medicines
How pharmacists can improve the lives of people living with disabilities through careful medicine reviews and follow-up.
Just like medicine safety challenges in aged care,...
Insomnia: a home medicines review case study
Pharmacists have an important role to play in the management of insomnia, including recommending non-pharmacological management.
Low-dose codeine use drops while prescriptions continue
Research from the University of New South Wales National Drug & Alcohol Research Centre (NDARC) has shown a decline in illicit low-dose codeine use...
Understanding CDK4/6 inhibitors
ADVERTORIAL BY LILLY
The management of advanced breast cancer continues to evolve, particularly in the frontline setting. To boost the success of endocrine therapies, cyclin-dependent...
Advances in understanding obesity
Traditional health advice about this global epidemic emphasises behavioural change above all while failing to recognise obesity as a disease.
What defined pharmacy practice in 2025?
The most-read stories of the year highlight where clinical practice, regulation and professional reform collided.
From sweeping Therapeutic Guidelines updates to unresolved scheduling decisions and...
